---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292911963.md"
description: "Arbutus Biopharma shares are trading higher after the company announced the filing of three international lawsuits seeking to enforce patent protecting LNP technology against Pfizer, BioNTech and certain or other affiliates."
datetime: "2026-07-16T13:08:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292911963.md)
  - [en](https://longbridge.com/en/news/292911963.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292911963.md)
generator: "portal-rs"
---

# 

Arbutus Biopharma shares are trading higher after the company announced the filing of three international lawsuits seeking to enforce patent protecting LNP technology against Pfizer, BioNTech and certain or other affiliates.

### Related Stocks

- [BNTX.US](https://longbridge.com/en/quote/BNTX.US.md)
- [ABUS.US](https://longbridge.com/en/quote/ABUS.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)

## Related News & Research

- [BioNTech CEO Uğur Şahin sells 20,500 shares for $1.97 million](https://longbridge.com/en/news/298771056.md)
- [How Trial Termination At BioNTech (BNTX) Has Changed Its Investment Story](https://longbridge.com/en/news/298362785.md)
- [BioNTech says lung cancer drug candidate prolonged lives in trial](https://longbridge.com/en/news/298884861.md)
- [BioNTech CEO Ugur Sahin sells ordinary shares worth $7.86 million](https://longbridge.com/en/news/298360154.md)
- [Novartis India acquires Pfizer brands for $132m](https://longbridge.com/en/news/298290980.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**